Table 6.V.
Phase III De-ESCALaTE HPV trial.
| Cisplatin | Cetuximab | ||
|---|---|---|---|
| 2-year OS | 97.5% | 89.4% | p = 0.0012 |
| 2-year recurrence rate | 6% | 16.1% | p = 0.0007 |
| Stage I/II OS | 98.4% | 93.2% | p = 0.048 |
| Stage III OS | 93.3% | 67.1% | p = 0.0304 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.